Chapter 27: Women's Health

Women's Health delivers a comprehensive and highly detailed overview of women's health across the lifespan, emphasizing the critical role of preventive care, rigorous health maintenance, and routine screening protocols such as mammography, Papanicolaou (Pap) testing, and dual-energy x-ray absorptiometry (DEXA) to detect anomalies early. It thoroughly examines cardiovascular disease as the primary cause of mortality among women, outlining essential risk factors, atypical symptomatic presentations, and actionable risk-reduction strategies like nutritional counseling and hypertension management. The text extensively covers both benign and malignant disorders of the breast, detailing non-cancerous conditions like fibrocystic changes and fibroadenomas, alongside the pathophysiology, genetic risk factors (such as BRCA mutations), clinical staging, surgical interventions, and adjuvant therapies associated with malignant breast tumors. Furthermore, the chapter delves into menstrual cycle abnormalities, providing clinical insights into primary and secondary amenorrhea, dysfunctional uterine bleeding, dysmenorrhea, endometriosis, and the evidence-based management of premenstrual syndrome (PMS). The physiological, psychosocial, and endocrine transitions of the climacteric phase, specifically menopause, are explored in depth, highlighting the systemic impacts of estrogen depletion, the complexities and evidenced-based risks of hormone replacement therapy (HRT), and the prevention of osteoporosis through pharmacological agents (such as bisphosphonates) and lifestyle modifications. Structural pelvic floor dysfunctions, including cystocele, rectocele, and uterine prolapse, are discussed alongside their respective conservative and surgical treatments to manage issues like urinary incontinence. Finally, the chapter addresses the pathology and management of benign reproductive tract growths, such as uterine leiomyomas and ovarian cysts, as well as malignant reproductive tract cancers (cervical, endometrial, and ovarian), concluding with an extensive clinical review of infectious diseases, spanning candidiasis, sexually transmitted infections (including HPV, HIV, chlamydia, gonorrhea, and syphilis), pelvic inflammatory disease (PID), and the life-threatening complications of toxic shock syndrome.